Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid (Q36959227)

17 August 2017

Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid (English)

1 reference

17 August 2017

Hang Xie

1

1 reference

17 August 2017

Teresa Liu

2

1 reference

17 August 2017

Hong Chen

3

1 reference

17 August 2017

Xiaoyuan Huang

4

1 reference

17 August 2017

Zhiping Ye

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

14 September 2007

1 reference

17 August 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 August 2017

25

1 reference

17 August 2017

44

1 reference

17 August 2017

7649-7655

1 reference

Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Rapid-response vaccines--does DNA offer a solution?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Influenza virus matrix protein is the major driving force in virus budding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an alpha-actin intronic enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Restriction of viral replication by mutation of the influenza virus matrix protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.052

10.1016/J.VACCINE.2007.08.052

7 January 2021

Identifiers

DOI

1 reference

release_sshepgjq5jfirjmqlm754l5dcu

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sshepgjq5jfirjmqlm754l5dcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference